GPCR logo

Structure Therapeutics Inc. (GPCR)

Profile

Full Name

Structure Therapeutics Inc.

Ticker

NASDAQ: GPCR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 3, 2023

Indexes

Not included

Website

https://structuretx.com

Employees

183

Key Details

Price

$19.14(+0.74%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$2.34(+3.57% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $19.14
    GPCR price is $19.14

    30-Day Relative Volume

    0.48
    GPCR 30-day relative volume is 0.48

    Price Performance

    Price Most recent change

    +0.74%
    GPCR price was up +0.74% on Aug 28, 2025

    Price YTD change

    -29.42%
    GPCR price is down -29.42% since January 1st

    Price 1-year change

    -51.36%
    GPCR price is down -51.36% year-on-year

    Price 3-year change

    -
    GPCR price 3-year change is unknown

    Price Range

    Price All-time high

    $75.02
    GPCR price is currently -74.49% below its historical high of $75.02

    Price 3-year low

    $13.22
    GPCR price is currently +44.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.10B
    GPCR market capitalization is $1.10 billion

    Market cap 3-year change

    -
    GPCR market capitalization 3-year change is unknown

    Market cap All-time high

    $3.45B
    GPCR market capitalization is currently -68.01% below its historical high of $3.45 billion

    Market cap sector rank

    73.71%
    GPCR market capitalization is higher than 73.71% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.7%
    GPCR shares outstanding is up +0.7% year-on-year

    Shares Outstanding 3-Year Change

    +57.42%
    GPCR shares outstanding is up +57.42% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.85
    GPCR beta is 0.85

    200-day SMA

    $23.90
    GPCR price is currently -19.93% below its 200-day simple moving average

    50-day SMA

    $19.07
    GPCR price is currently +0.35% above its 50-day simple moving average

    RSI

    52.98
    GPCR 14-day relative strength index is 52.98

    Volume

    0.48
    GPCR 30-day relative volume is 0.48

    ATR

    $1.01
    GPCR average true range is $1.01

    10-day Historical Volatility

    66.87%
    GPCR 10-day historical volatility is 66.87%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    GPCR annual revenue is $0.00

    Revenue Analysts estimate

    $45.45M
    GPCR annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    0%
    GPCR annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.72%
    GPCR annual revenue is higher than 28.72% of companies in Healthcare sector

    EPS

    EPS

    -$2.34
    GPCR annual earnings per share is -$2.34

    EPS Analysts estimate

    -$1.24
    GPCR annual earnings per share is currently +88.06% higher than the consensus analysts' forecast

    EPS 1-year change

    +3.57%
    GPCR annual earnings per share is up +3.57% year-on-year

    EPS Sector rank

    34.5%
    GPCR annual earnings per share is higher than 34.5% of companies in Healthcare sector

    Profit

    Gross profit

    -$2.60M
    GPCR annual gross profit is -$2.60 million

    Gross margin

    -
    GPCR annual gross profit margin value is unknown

    Operating profit

    -$158.23M
    GPCR annual operating income is -$158.23 million

    Operating margin

    -
    GPCR annual operating profit margin value is unknown

    Net income

    -$122.59M
    GPCR annual net profit is -$122.59 million

    Net margin

    -
    GPCR annual net profit margin value is unknown

    Expenses

    Total expenses

    $158.23M
    GPCR annual total expenses is $158.23 million

    Operating expenses

    $158.23M
    GPCR annual total operating expenses is $158.23 million

    Cost of goods sold

    $2.60M
    GPCR annual cost of goods sold is $2.60 million

    Selling, general & administrative expenses

    $49.41M
    GPCR annual SGA is $49.41 million

    Depreciation and amortization

    $992.00K
    GPCR annual depreciation & amortization is $992.00 thousand

    Interest expense

    $0.00
    GPCR annual interest expense is $0.00

    Income tax

    $310.00K
    GPCR annual income tax is $310.00 thousand

    EBIT & EBITDA

    EBIT

    -$158.23M
    GPCR annual earnings before interest & taxes is -$158.23 million

    EBITDA

    -$157.24M
    GPCR annual EBITDA is -$157.24 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $903.33M
    GPCR annual total assets is $903.33 million

    Non current assets

    $12.12M
    GPCR annual long term assets is $12.12 million

    Current assets

    $891.21M
    GPCR annual total current assets is $891.21 million

    Cash and cash equivalents

    $169.51M
    GPCR annual cash & cash equivalents is $169.51 million

    Accounts receivable

    -
    GPCR annual accounts receivable value is unknown

    Inventory

    $0.00
    GPCR annual inventory is $0.00

    Liabilities

    Total liabilities

    $38.49M
    GPCR annual total liabilities is $38.49 million

    Long term liabilities

    $2.47M
    GPCR annual total long term liabilities is $2.47 million

    Current liabilities

    $36.02M
    GPCR annual total current liabilities is $36.02 million

    Accounts payable

    $8.02M
    GPCR annual accounts payable is $8.02 million

    Debt

    Total debt

    $3.86M
    GPCR annual total debt is $3.86 million

    Total debt 1-year change

    -29.18%
    GPCR annual total debt is down -29.18% year-on-year

    Long term debt

    $2.16M
    GPCR annual long term debt is $2.16 million

    Short term debt

    $1.70M
    GPCR annual short term debt is $1.70 million

    Equity & Capital

    Shareholders equity

    $864.84M
    GPCR annual stockholders equity is $864.84 million

    Book value

    $864.84M
    GPCR annual book value is $864.84 million

    Retained earnings

    -$329.10M
    GPCR annual retained earnings is -$329.10 million

    Working capital

    $855.19M
    GPCR annual working capital is $855.19 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$116.64M
    GPCR annual cash flow from operations is -$116.64 million

    Cash from operations 1-year change

    -46.73%
    GPCR annual cash flow from operations is down -46.73% year-on-year

    Cash from investing

    -$358.91M
    GPCR annual cash flow from investing activities is -$358.91 million

    Cash from investing 1-year change

    -33.75%
    GPCR annual cash flow from investing activities is down -33.75% year-on-year

    Cash from financing

    $515.26M
    GPCR annual cash flow from financing activities is $515.26 million

    Cash from financing 1-year change

    +14.11%
    GPCR annual cash flow from financing activities is up +14.11% year-on-year

    CAPEX

    CAPEX

    $1.29M
    GPCR annual capital expenditures is $1.29 million

    CAPEX 1-year change

    -40.39%
    GPCR annual capital expenditures is down -40.39% year-on-year

    Free Cash Flow

    Free cash flow

    -$117.93M
    GPCR annual free cash flow is -$117.93 million

    Free cash flow 1-year change

    -44.42%
    GPCR annual free cash flow is down -44.42% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    GPCR annual gross profit margin value is unknown

    Operating margin

    -
    GPCR annual operating profit margin value is unknown

    Net margin

    -
    GPCR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -17.70%
    GPCR annual return on assets is -17.70%

    ROE

    -18.60%
    GPCR annual return on equity is -18.60%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    GPCR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    GPCR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.43
    GPCR price to book ratio is 1.43

    PB ratio Sector rank

    44.01%
    GPCR price to book ratio is higher than 44.01% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    GPCR price to sales ratio value is unknown

    PS ratio Sector rank

    -
    GPCR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $323.59M
    GPCR enterprise value is $323.59 million

    Enterprise value Sector rank

    61.65%
    GPCR enterprise value is higher than 61.65% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.48
    GPCR EV/EBITDA is -1.48

    EV/EBITDA Sector rank

    41.01%
    GPCR EV/EBITDA is higher than 41.01% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    24.74
    GPCR annual current ratio is 24.74

    Quick ratio

    24.74
    GPCR annual quick ratio is 24.74

    Leverage

    Debt to equity

    0.00
    GPCR annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    GPCR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    GPCR piotroski f-score value is unknown

    Altman Z-Score

    17.23
    GPCR altman z-score is 17.23

    Analyst ratings

    Recent major analysts updates

    Aug 7, 25 JMP Securities
    Market Outperform
    Aug 7, 25 HC Wainwright & Co.
    Buy
    Aug 7, 25 Guggenheim
    Buy
    Jun 23, 25 JMP Securities
    Market Outperform
    Jun 23, 25 Cantor Fitzgerald
    Overweight
    May 12, 25 HC Wainwright & Co.
    Buy
    May 2, 25 Citigroup
    Buy
    Apr 22, 25 HC Wainwright & Co.
    Buy
    Feb 28, 25 William Blair
    Outperform
    Feb 28, 25 Citizens Capital Markets
    Market Outperform

    Institutional Ownership

    Screeners with GPCR included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Structure Therapeutics Inc.?
    • Does Structure Therapeutics Inc. pay dividends?
    • What sector is Structure Therapeutics Inc. in?
    • What industry is Structure Therapeutics Inc. in?
    • What country is Structure Therapeutics Inc. based in?
    • When did Structure Therapeutics Inc. go public?
    • Is Structure Therapeutics Inc. in the S&P 500?
    • Is Structure Therapeutics Inc. in the NASDAQ 100?
    • Is Structure Therapeutics Inc. in the Dow Jones?
    • When was Structure Therapeutics Inc.'s last earnings report?
    • When does Structure Therapeutics Inc. report earnings?

    What is the ticker symbol for Structure Therapeutics Inc.?

    The ticker symbol for Structure Therapeutics Inc. is NASDAQ:GPCR

    Does Structure Therapeutics Inc. pay dividends?

    No, Structure Therapeutics Inc. does not pay dividends

    What sector is Structure Therapeutics Inc. in?

    Structure Therapeutics Inc. is in the Healthcare sector

    What industry is Structure Therapeutics Inc. in?

    Structure Therapeutics Inc. is in the Biotechnology industry

    What country is Structure Therapeutics Inc. based in?

    Structure Therapeutics Inc. is headquartered in United States

    When did Structure Therapeutics Inc. go public?

    Structure Therapeutics Inc.'s initial public offering (IPO) was on February 3, 2023

    Is Structure Therapeutics Inc. in the S&P 500?

    No, Structure Therapeutics Inc. is not included in the S&P 500 index

    Is Structure Therapeutics Inc. in the NASDAQ 100?

    No, Structure Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Structure Therapeutics Inc. in the Dow Jones?

    No, Structure Therapeutics Inc. is not included in the Dow Jones index

    When was Structure Therapeutics Inc.'s last earnings report?

    Structure Therapeutics Inc.'s most recent earnings report was on May 8, 2025

    When does Structure Therapeutics Inc. report earnings?

    The next expected earnings date for Structure Therapeutics Inc. is November 10, 2025
    On this page